Correction to: Positive diepoxybutane test in a patient with Nijmegen Breakage Syndrome (Pediatric Blood & Cancer, (2007), 49, 1, (110), 10.1002/pbc.20941);Positive diepoxybutane test in a patient with Nijmegen breakage syndrome [5]

Pediatric Blood and Cancer

Volumn 49, Issue 1, 2007, Pages 110-

  Gallego, Marta S ^a,b   Barreiro, C Z ^a   Danielian, S ^a   Rosenweig, S D ^a  

^a Hospital de Pediatria SAMIC Prof Dr Juan P Garrahan   (Argentina)

^b HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BUTADIENE DIEPOXIDE;

ADOLESCENT; CASE REPORT; CLINICAL FEATURE; CYTOGENETICS; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; FANCONI ANEMIA; FEMALE; GENE MUTATION; HUMAN; LETTER; NIJMEGEN BREAKAGE SYNDROME; PRIORITY JOURNAL;

EID: 34249797615     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.30827     Document Type: Erratum

References (4)

1. New HV, Cale CM, Tischkowitz M, et al. Nijmegen Breakage Syndrome diagnosed as Fanconi Anaemia. Pediatr Blood Cancer 2005;44:494-499.
2. Rosenzweig SD, Russo AG, Gallego MS, et al. Juvenile rheumatoid arthritis like polyarthritis in Nijmegen Breakage Syndrome. J Rheumatol 2001;28:2548-2550.
3. Gennery AR, Slater MA, Bhattacharya A, et al. The clinical and biological overlap between Nijmegen Breakage Syndrome and Fanconi Anemia. Clin Immunol 2004;113:214-219.
4. Nakanishi K, Toshiyasu T, Velvizhi R, et al. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol 2002;4:913-920.